Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas
- PMID: 1186274
Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas
Abstract
The analysis of a series of 1,225 cases of reflux esophagitis shows the serious nature of this condition. A liberal use of antireflux operations therefore seems justified. Extensive columnar metaplasia of the distal esophagus, or columnar-lined lower esophagus (CLLE), represents a late irreversible stage of reflux esophagitis. Repeated esophagoscopies demonstrate the acquired nature of the lesion. It is caused by the progressive healing, from below upward, of peptic ulcerations on the squamous epithelium by metaplasia of columnar mucosa. Antireflux operations stop the progressive ascent of heterotopic epithelium and thus stabilize reflux esophagitis and cure complications such as ulcerations and strictures. The premalignant character of this condition is established by a 10 per cent incidence of adenocarcinomas in a series of 140 cases of extensive columnar metaplasia. The transition toward malignancy seems to be irreversible and cannot be arrested by an antireflux operation. Therefore, repeated esophagoscopic controls and biopsies are an absolute necessity in all cases of extensive columnar metaplasia, even after cure of active reflux esophagitis by Nissen fundoplication.
Similar articles
-
[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].Zentralbl Chir. 2004 Apr;129(2):99-103. doi: 10.1055/s-2004-816278. Zentralbl Chir. 2004. PMID: 15106039 German.
-
Multiple adenomatous neoplasms arising in columnarlined (Barrett's) esophagus.Gastroenterology. 1977 Jun;72(6):1317-21. Gastroenterology. 1977. PMID: 858475
-
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.Am J Gastroenterol. 2005 Jun;100(6):1257-64. doi: 10.1111/j.1572-0241.2005.41338.x. Am J Gastroenterol. 2005. PMID: 15929754
-
Diagnosis and treatment of Barrett's oesophagus. A general survey.Acta Chir Belg. 2001 Mar-Apr;101(2):53-8. Acta Chir Belg. 2001. PMID: 11396051 Review.
-
[Barrett's metaplasia].Folia Med Cracov. 1999;40(3-4):5-16. Folia Med Cracov. 1999. PMID: 10909470 Review. Polish.
Cited by
-
Barrett's esophagus in children and young adults. Frequent association with mental retardation.Dig Dis Sci. 1990 Oct;35(10):1185-9. doi: 10.1007/BF01536405. Dig Dis Sci. 1990. PMID: 2209285
-
Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003.Br J Cancer. 2007 Jun 4;96(11):1767-71. doi: 10.1038/sj.bjc.6603798. Epub 2007 May 15. Br J Cancer. 2007. PMID: 17505507 Free PMC article.
-
The effect of reactive atypia/inflammation on the laser-induced fluorescence diagnosis of non-dysplastic Barrett's esophagus.Lasers Surg Med. 2012 Jul;44(5):390-6. doi: 10.1002/lsm.22033. Epub 2012 Apr 25. Lasers Surg Med. 2012. PMID: 22535652 Free PMC article.
-
Screening for gastrointestinal cancer: an epidemiological review.Gut. 1991 Feb;32(2):220-4. doi: 10.1136/gut.32.2.220. Gut. 1991. PMID: 1864546 Free PMC article. Review. No abstract available.
-
Adenocarcinoma in Barrett's oesophagus: an overrated risk.Gut. 1989 Jan;30(1):14-8. doi: 10.1136/gut.30.1.14. Gut. 1989. PMID: 2920919 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources